TROX FY2025 SEC EDGAR DEF 14A #34 of 168 in industry

Tronox Holdings plc CEO pay ratio

The CEO earned $8.2M in FY2025 against median worker pay of $68,061 · Chemicals & Pharmaceuticals.

State
X0
Filing date
2026-03-19
Industry
Chemicals & Pharmaceuticals
Industry rank
#34/168

Data updated August 2026

Subscribe to Tronox Holdings plc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
121:1
Moderate (Scale: 0–1000:1)
CEO pay
$8.2M
Median worker
$68,061

Answer first

Tronox Holdings plc's FY2025 CEO total of $8.2M ranks #661 of 1,423 complete filings; its 121:1 pay ratio ranks #541. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $68,061. Industry placement uses the FY2025 SIC-28 peer cohort (# 34 of 168, 80th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#661
$8.2M of 1,423 FY2025
Ratio rank
#541
121:1 of 1,423
Industry pct
80th
top quartile of industry peers by pay ratio

How Tronox Holdings plc ranks nationally

Tronox Holdings plc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$8,235,381 Top 46% higher than 54% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). This entry sits in this band. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Tronox Holdings plc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($8.2M) against pay ratio (121:1) for Tronox Holdings plc (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both7637807.59077309.010516810.511956312.013395813.637.8:161.1:184.5:1107.9:1131.3:1CEO total payPay ratio (CEO : median worker)Tronox Holdings plc, CEO total pay: 8235381 · Pay ratio (CEO : median worker): 121:1Tronox Holdings plcAdma Biologics, Inc., CEO total pay: 10237326 · Pay ratio (CEO : median worker): 120:1Adma Biologics, Inc.Ingevity Corp, CEO total pay: 13134086 · Pay ratio (CEO : median worker): 127:1Ingevity CorpAni Pharmaceuticals Inc, CEO total pay: 10254756 · Pay ratio (CEO : median worker): 114:1Ani Pharmaceuticals IncPerimeter Solutions, Inc., CEO total pay: 8062080 · Pay ratio (CEO : median worker): 114:1Perimeter Solutions, Inc.
Tronox Holdings plc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Tronox Holdings plc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Tronox Holdings plc

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
121:1
FY2025
vs prior FY
-23:1
from FY2024 144:1
CEO $ YoY
-4.2%
$8.2M latest
Filings shown
5
FY2021–2025
Tronox Holdings plc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $5.1M - $61,101 84:1 -
2022 $4.7M -8.2% $54,761 86:1 +2:1
2023 $5.3M +13% $62,337 85:1 -1:1
2024 $8.6M +62% $59,711 144:1 +59:1
2025 $8.2M -4.2% $68,061 121:1 -23:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1530804, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
121:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$8.2M
Companies in Industry
168
vs. Industry Median
Above
#34 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Tronox Holdings plc: MID · HEAVY pay ratio

Tronox Holdings plc's FY2025 ratio 121:1 ranks #34 of 168 Chemicals & Pharmaceuticals filers (80th percentile). the CEO earned 121× the median employee ($68,061) in FY2025.

Median employee $68,061 (PAR-MED); MID · HEAVY stamps put about 121 median-wage years per CEO year.

CEO Total Pay

$8.2M

FY2025 Summary Compensation, near median

Pay Ratio

121:1

Near industry median

Tronox Holdings plc in the higher Chemicals & Pharmaceuticals third

Tronox Holdings plc's FY2025 ratio 121:1 ranks #34 of 168 Chemicals & Pharmaceuticals filers (80th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Tronox Holdings plc's $8.2M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #661 and ratio rank #541 split - treat 121:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$8.2M
Median Employee Pay
$68,061
Pay Ratio
121:1
Filing Date
2026-03-19

Company Info

Ticker
TROX
CIK
1530804
Industry
Chemicals & Pharmaceuticals
SIC Code
2810
State
X0
SEC EDGAR DEF 14A for CIK 1530804, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read with Tronox Holdings plc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · PAR-MED.

Data sourced from SEC EDGAR DEF 14A for Tronox Holdings plc (CIK 1530804), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.